Contact
Quote
ScreenCell® logo
Request a Demo

Analysis of Circulating Tumor Cells (CTCs) in Patients with Metastatic Melanoma Before and During Systemic Treatment

  • Last updated:18 December 2025

General information about the study

Type of cancer:

  • Melanoma

Type of study:

  • Observational

Status of the study:

  • Analysis in progress

Investigative center:

  • Gustave Roussy

Main objective(s):

To evaluate the prognostic and predictive value of treatment efficacy based on changes in circulating tumor cell (CTC) counts during treatment.

Study references​

Official title:

  • Analysis of Circulating Tumor Cells (CTCs) in Patients with Metastatic Melanoma Before and During Systemic Treatment

Our latest clinical trials

In progress

 

Analysis of Circulating Tumor Cells (CTCs) in Patients with Metastatic Melanoma Before and During Systemic Treatment

Type of cancer:

  • Melanoma

Trial status:

  • Analysis in progress
View clinical trial

In progress

 

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device (PROBE-CTC)

Type of cancer:

  • Breast cancer

Trial status:

  • Active recruitment
View clinical trial

Completed

 

Evaluation of Circulating Tumor Cells (CTCs) by the ScreenCell® device in breast cancer: validation of biomarkers

Type of cancer:

  • Metastatic breast cancer

Trial status:

  • Completed
View clinical trial
See the clinical trials

Want to learn more?

Download our brochure

Products news

ScreenCell® will standardize its range of CTC isolation kits by 2026

Read the news

Follow ScreenCell® on LinkedIn

Subscribe